passages.id: split_4_validation_435_passage
passages.type: progene_text
passages.text: rHuIL-11 has recently demonstrated immunomodulatory activity to downregulate IFN-gamma production , increase IL-4 production , and reduce inflammatory tissue injury in a human psoriasis clinical trial .